Roy F. A. Vliegen
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Roy F. A. Vliegen has a total of 17 co-authors. Here are the top co-authors by number of shared publications:
- Geerard L. Beets
GROW School for Oncology and Developmental Biology, Maastricht University Medical Centre, P. Debyelaan 25, Maastricht, The Netherlands
2 shared publications Alette Daniels-Gooszen
University Hospital of Maastricht
1 shared publicationAlfons G. Kessels
University Hospital Maastricht
1 shared publicationAlfons Kessels
University Hospital of Maastricht
1 shared publicationAngela van Baardwijk
University Hospital Maastricht
1 shared publicationAnn Arens
University Hospital Maastricht
1 shared publication
Latest Publications
- 1 February 2013
- Published by Springer Nature in European Journal of Nuclear Medicine and Molecular Imaging
- Vol. 40  (4) , 475-476
Predicting tumour response to chemoradiotherapy in oesophageal cancer by early interim 18F-FDG PET: where do we stand and where should we go?
- 1 February 2013
- Published by Springer Nature in European Journal of Nuclear Medicine and Molecular Imaging
- Vol. 40  (4) , 475-476
Predicting tumour response to chemoradiotherapy in oesophageal cancer by early interim 18F-FDG PET: where do we stand and where should we go?
- 19 September 2008
- Published by Springer Nature in Strahlentherapie und Onkologie
- Vol. 184  (9) , 457-464
Can an FDG-PET/CT Predict Tumor Clearance of the Mesorectal Fascia after Preoperative Chemoradiation of Locally Advanced Rectal Cancer?
More effective preoperative treatment in locally advanced rectal cancer gives rise to a more individualized, conservative surgical treatment strategy. This, however, requires accurate information on tumor response after chemoradiation (CRT). So far, MRI and CT have failed to provide such information. Therefore, the value of a combined FDG-PET/CT in predicting tumor clearance of the mesorectal fascia (MRF) was determined.
- 19 September 2008
- Published by Springer Nature in Strahlentherapie und Onkologie
- Vol. 184  (9) , 457-464
Can an FDG-PET/CT Predict Tumor Clearance of the Mesorectal Fascia after Preoperative Chemoradiation of Locally Advanced Rectal Cancer?
More effective preoperative treatment in locally advanced rectal cancer gives rise to a more individualized, conservative surgical treatment strategy. This, however, requires accurate information on tumor response after chemoradiation (CRT). So far, MRI and CT have failed to provide such information. Therefore, the value of a combined FDG-PET/CT in predicting tumor clearance of the mesorectal fascia (MRF) was determined.
- Open Access
- 3 January 2008
- Published by Springer Nature in Abdominal Radiology
- Vol. 33  (5) , 604-610
The accuracy of Multi-detector row CT for the assessment of tumor invasion of the mesorectal fascia in primary rectal cancer
To evaluate the accuracy of Multi-detector row CT (MDCT) for the prediction of tumor invasion of the mesorectal fascia (MRF).
- 3 January 2008
- Published by Springer Nature in Abdominal Radiology
- Vol. 33  (5) , 604-610
Open AccessThe accuracy of Multi-detector row CT for the assessment of tumor invasion of the mesorectal fascia in primary rectal cancer
To evaluate the accuracy of Multi-detector row CT (MDCT) for the prediction of tumor invasion of the mesorectal fascia (MRF).